Clinical Trials in Arizona

Showing 16161-16180 of 16,770 trials

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

NCT00842400

The purposes of this study are to: * Find out how much of the study drugs are in the blood of healthy subjects after taking multiple doses of VI-0521, metformin and sitagliptan. * Determine the effect of probenecid on the amount of VI-0521 in the blood of healthy subjects after taking multiple doses. * Find out how much topiramate is in the semen of healthy male subjects after taking multiple doses.

Obesity

VIVUS LLC20 participantsStarted Feb 2009

Phoenix, Arizona, United States

COMPLETEDPhase 142 miles

Safety and Tolerability Study of the Taris Placebo System

NCT01051336

The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.

Healthy

TARIS Biomedical, Inc.10 participantsStarted Oct 2009

Phoenix, Arizona, United States

TERMINATEDPhase 342 miles

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

NCT00141011

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.

StrokeCerebral IschemiaBrain Infarction

Neurobiological Technologies277 participantsStarted Sep 2005

Phoenix, Arizona, United States • Fort Smith, Arkansas, United States • Loma Linda, California, United States +97 more locations

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

Safety and Tolerability Study of the Taris Placebo System

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Find Trials by Condition in Arizona

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Memory Impairment Study (Mild Cognitive Impairment Study)

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects

A Phase III Trial For Patients With Metastatic Breast Cancer

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

International Immune Tolerance Study

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Quality of Life in Pediatric Inflammatory Bowel Disease

North American Study for the Treatment of Refractory Ascites (NASTRA)